Jemperli 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
7680680230015
CH-68023
Konzentrat
Associated product:
JEMPERLI conc perf 500 mg/10ml amp 10 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
22.78 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5364.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2022
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68023
- Drug name
- Jemperli, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF07
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 17/02/2022
- Authorization expiration date
- 21/12/2028
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- JEMPERLI conc perf 500 mg/10ml amp 10 ml
- Description (DE)
- JEMPERLI Inf Konz 500 mg/10ml Amp 10 ml
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No